The Lancet on X: "Both vaccine doses induced significant neutralising antibody responses to live SARS-CoV-2, with GMT of 19.5 & 18.3 in participants receiving high & low dose, respectively. Binding antibody response
Antibody | Definition, Structure, Function, & Types | Britannica
Quantification of Severe Acute Respiratory Syndrome Coronavirus 2 Binding Antibody Levels To Assess Infection and Vaccine-Induced Immunity Using WHO Standards | Microbiology Spectrum
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study - The Lancet Healthy Longevity
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 | Nature
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis - The Lancet Microbe
SARS CoV-2 Neutralizing Antibody Detection Kit | GenScript
Comparison of the binding antibody units per milliliter (BAU/mL) ratio... | Download Scientific Diagram
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders | Journal of Hematology & Oncology | Full Text
Towards a population-based threshold of protection for COVID-19 vaccines - ScienceDirect
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 | Science
Antibody - Wikipedia
Humoral immune response after different SARS-CoV-2 vaccination regimens | BMC Medicine | Full Text
JCI - COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain
KD value: a quantitative measurement of antibody affinity | Abcam
Comparison of the binding antibody units per milliliter (BAU/mL) ratio... | Download Scientific Diagram
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability - ScienceDirect
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes | Nature Communications
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection | Nature Medicine
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection | Microbiology Spectrum
Guide to Antibody structure and isotypes | Abcam
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants | npj Vaccines
Frontiers | Memory SARS-CoV-2 T-cell response in convalescent COVID-19 patients with undetectable specific IgG antibodies: a comparative study
Frontiers | Harmonization of Multiple SARS-CoV-2 Reference Materials Using the WHO IS (NIBSC 20/136): Results and Implications
